Snowball logo
logo
TVTX

Travere Therapeutics Inc

TVTX โ€ข NASDAQ
$28.96-$2.479999ย  (7.89%)

Frequently asked questions

What sector does Travere Therapeutics Inc (TVTX) operate in?

Travere Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Travere Therapeutics Inc (TVTX) current stock price?

As of the latest data, Travere Therapeutics Inc stock price is $28.96, with a previous close of $31.44. Travere Therapeutics Inc lost -$2.48 in the last trading session, representing a -7.89% loss.

What is Travere Therapeutics Inc (TVTX) current market capitalization?

Travere Therapeutics Inc market cap is approximately 2.67 billion.

What is Travere Therapeutics Inc (TVTX) Earnings Per Share (EPS)?

The trailing EPS is -$0.57, and the forward EPS is $4.26.

What is Travere Therapeutics Inc (TVTX) EBITDA?

Travere Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -632.00 thousand.

Does Travere Therapeutics Inc (TVTX) pay dividends?

No. Travere Therapeutics Inc does not pay a dividend.

How did Travere Therapeutics Inc (TVTX) perform in its most recent earnings report?

In the last report (December 31, 2025), Travere Therapeutics Inc posted an EPS surprise of 1,025% and a revenue surprise of -74.49%.

When is Travere Therapeutics Inc (TVTX) next earnings report?

Travere Therapeutics Inc is expected to release its next earnings report on March 31, 2026.

What is Travere Therapeutics Inc (TVTX) beta (volatility) score?

Travere Therapeutics Inc has a beta of 0.884, meaning its volatility is roughly in line with the market.